Absence of measles-virus genome in inflammatory bowel disease

Lancet

Volumn 351, Issue 9103, 1998, Pages 646-647

  Afzal, M A ^a   Minor, P D ^b   Begley, J ^b   Bentley, M L ^b   Armitage, E ^b   Ghosh, S ^b   Ferguson, A ^b  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

MEASLES VACCINE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENTERITIS; GENOME; HUMAN; MEASLES VACCINATION; MEASLES VIRUS; PRIORITY JOURNAL; VIRUS DETECTION;

EID: 0032574257     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)78429-4     Document Type: Article

References (5)

1. 1 Ekbom A, Wakefield AJ, Zack M, Adami HO. Potential measles infection and subsequent Crohn's disease. Lancet 1994; 344: 508-10.
2. 2 Ekbom A, Daszak P, Kraaz W, Wakefield AJ. Crohn's disesase after in-utero measles virus exposure. Lancet 1996; 348: 515-17.
3. 3 Thompson NP, Montgomery SM, Pounder RE, Wakefield AJ. Is measles vaccination a risk factor for inflammatory bowel disease? Lancet 1995; 345: 1071-74.
4. 4 Wakefield AJ, Pittilo RM, Sim R, et al. Evidence of persistent measles virus infection in Crohn's disease. J Med Virol 1993; 39: 345-53.
5. 5 Wakefield AJ, Sim R, Akbar AN, Pounder RE, Dhillon AP. In situ immune response in Crohn's disease: a comparison with acute and persistent measles virus infection. J Med Virol 1997; 51: 90-100.